Takeda Pharmaceutical Company Ownership | Who Owns Takeda Pharmaceutical Company?

Overview RevenueFinancials Chart Transcripts

Takeda Pharmaceutical Company Ownership Summary

Takeda Pharmaceutical Company is owned by 4.60% institutional investors, 0.01% insiders, and 95.39% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.84% of TAK shares. Capital Group American Mutual Comp is the top mutual fund, with 0.41% of its assets in Takeda Pharmaceutical Company shares.

TAK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Takeda Pharmaceutical Company	4.60%	0.01%	95.39%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Specialty & Generic Drug Manufacturers Stocks	33.68%	9.20%	57.12%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital research global investors	13.13M	0.84%	$169.86M
Mondrian investment partners	7.74M	0.49%	$108.34M
Morgan stanley	4.99M	0.32%	$64.53M
Millennium management	4.35M	0.28%	$56.24M
Goldman sachs group	3.72M	0.24%	$48.10M
Renaissance	2.95M	0.19%	$38.24M
Brandes investment partners, lp	2.64M	0.17%	$34.05M
Fmr	2.62M	0.17%	$33.94M
Arrowstreet capital, limited partnership	2.32M	0.15%	$29.96M
Van eck associates	2.04M	0.13%	$26.41M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Managed asset portfolios	1.61M	3.10%	$20.88M
Xy capital	344.05K	2.81%	$4.45M
Clean yield group	445.14K	2.15%	$5.76M
Mondrian investment partners	7.74M	1.67%	$108.34M
Legacy wealth asset management	164.41K	0.60%	$2.13M
Causeway capital management	1.35M	0.48%	$17.52M
Brandes investment partners, lp	2.64M	0.42%	$34.05M
Gold investment management	71.78K	0.39%	$928.78K
Summit global investments	223.41K	0.20%	$2.89M
Cowen and company	530.60K	0.19%	$6.87M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	4.35M	0.03%	2.02M
Arrowstreet capital, limited partnership	2.32M	0.03%	950.59K
Cowen and company	530.60K	0.19%	530.60K
Van eck associates	2.04M	0.04%	356.07K
Manning & napier advisors	316.69K	0.05%	316.69K

Top Sellers

Holder	Shares	% Assets	Change
Mondrian investment partners	7.74M	1.67%	-4.34M
Macquarie group	1.05M	0.02%	-1.20M
Bank of america corp /de/	867.06K	0.00%	-616.95K
Blackrock	1.44M	0.00%	-558.24K
Goldman sachs group	3.72M	0.01%	-491.97K

New Positions

Holder	Shares	% Assets	Change	Value
Cowen and company	530.60K	0.19%	530.60K	$6.87M
Manning & napier advisors	316.69K	0.05%	316.69K	$4.10M
Schonfeld strategic advisors	89.40K	0.01%	89.40K	$1.16M
Exchange traded concepts	35.72K	0.01%	35.72K	$462.15K
Ritholtz wealth management	24.32K	0.01%	24.32K	$314.69K

Sold Out

Holder	Change
Sugarloaf wealth management	-15.00
Ameritas investment partners	-15.00
Harbor investment advisory	-24.00
Baldwin brothers llc/ma	-35.00
Farmers & merchants investments	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	285	-10.94%	72,112,827	-7.86%	4	18.47%	120	-25.93%	101	21.69%
Mar 31, 2024	320	2.56%	78,262,422	-6.37%	4	17.57%	162	40.87%	83	-33.60%
Dec 31, 2023	312	-1.58%	83,587,817	3.95%	5	79.64%	115	-21.77%	125	34.41%
Sep 30, 2023	317	-0.31%	80,410,527	-4.27%	2	35.43%	147	8.89%	93	-4.12%
Jun 30, 2023	318	4.26%	84,000,772	-3.50%	2	34.47%	135	-12.90%	97	40.58%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Capital Group American Mutual Comp	12.94M	0.41%	-7.55K
American Funds American Mutual A	12.94M	0.41%	-7.55K
First Trust Value Line® Dividend ETF	3.20M	0.10%	-1.49K
VanEck Pharmaceutical ETF	2.18M	0.07%	14.70K
Mondrian Int Eq Delivered Strategy	816.00K	0.03%	-1.77M
MAP Global Equity Composite	706.97K	0.02%	6.83K
MAP Global Balanced Composite	521.00K	0.02%	3.45K
ActivePassive International Equity ETF	459.86K	0.01%	-
MAP Global Equity Ex-Options Composite	290.25K	0.01%	-1.88K
Avantis International Equity ETF	264.79K	0.01%	-

Insider Transactions Trends

Date	Buy	Sell
2022 Q4	-	-

TAK Ownership FAQ

Who Owns Takeda Pharmaceutical Company?

Takeda Pharmaceutical Company shareholders are primarily institutional investors at 4.60%, followed by 0.01% insiders and 95.39% retail investors. The average institutional ownership in Takeda Pharmaceutical Company's industry, Specialty & Generic Drug Manufacturers Stocks, is 33.68%, which Takeda Pharmaceutical Company falls below.

Who owns the most shares of Takeda Pharmaceutical Company?

Takeda Pharmaceutical Company’s largest shareholders are Capital research global investors (13.13M shares, 0.84%), Mondrian investment partners (7.74M shares, 0.49%), and Morgan stanley (4.99M shares, 0.32%). Together, they hold 1.65% of Takeda Pharmaceutical Company’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical Company?

BlackRock is not among the top 10 institutional shareholders of Takeda Pharmaceutical Company.

Who is Takeda Pharmaceutical Company’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical Company’s biggest shareholder by percentage of total assets invested, with 3.10% of its assets in 1.61M Takeda Pharmaceutical Company shares, valued at 20.88M$.

Who is the top mutual fund holder of Takeda Pharmaceutical Company shares?

Capital Group American Mutual Comp is the top mutual fund holder of Takeda Pharmaceutical Company shares, with 0.41% of its total shares outstanding invested in 12.94M Takeda Pharmaceutical Company shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools